Cargando…
Pharmacokinetic Study and Bioavailability of a Novel Synthetic Trioxane Antimalarial Compound 97/63 in Rats
Single dose pharmacokinetics study of 97/63 (IND191710, 2004), a trioxane antimalarial developed by Central Drug Research Institute, Lucknow, India, was studied in rats following intravenous and oral administration. Serum samples were analysed by HPLC-UV assay. Separation was achieved on a RP-18 col...
Autores principales: | Kushwaha, Hari Narayan, Mohan, Neel Kamal, Sharma, Ashok Kumar, Singh, Shio Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180634/ https://www.ncbi.nlm.nih.gov/pubmed/25302132 http://dx.doi.org/10.1155/2014/759392 |
Ejemplares similares
-
Time Course of the Changes in Novel Trioxane Antimalarial 99/411 Pharmacokinetics upon Antiepileptic Drugs Co-Administration in SD Rats
por: Singh, Yeshwant, et al.
Publicado: (2014) -
Novel series of 1,2,4-trioxane derivatives as antimalarial agents
por: Rudrapal, Mithun, et al.
Publicado: (2017) -
Solvent and Substituent Effects on the Thermolysis of Antimalarial Fluorophenyl Substituted 1,2.4-Trioxanes
por: Cafferata, Lazaro F. R., et al.
Publicado: (2003) -
Assessment of pharmacokinetic compatibility of short acting CDRI candidate trioxane derivative, 99–411, with long acting prescription antimalarials, lumefantrine and piperaquine
por: Taneja, Isha, et al.
Publicado: (2015) -
Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold
por: Rudrapal, Mithun, et al.
Publicado: (2016)